SXTP
60 Degrees Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.92
−1.16%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.61
- Revenue estimate
- $270.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.90
- EPS estimate
- -$0.74
- Revenue actual
- $210.0K
- Revenue estimate
- $185.8K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -36.5%
- Revenue beats (12Q)
- 4
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026